DIN 02378590 — CAPRELSA 300 MG
CAPRELSA is a tablet of Vandetanib marketed by SANOFI-AVENTIS CANADA INC. The full Vandetanib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02378590
- Brand name
- CAPRELSA
- Active ingredient
- Vandetanib
- Strength
- 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Multi-kinase inhibitor (VEGFR/EGFR/RET tyrosine kinase inhibitor, antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Vandetanib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02378582 | CAPRELSA | 100 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |